Sanofi and EVOQ Therapeutics Sign $500 Million Collaboration and Licensing Agreement

Ropes & Gray has advised Sanofi.Sanofi has entered into a collaboration and global license agreement with EVOQ Therapeutics to develop therapies for autoimmune diseases using EVOQ’s…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here